BioCentury | Mar 22, 2004
Company News

Corgenix Medical Corp., Genesis Bioventures deal

...of $0.80 on March 15. GBI said the merged company will focus on developing GBI's mammastatin...
BioCentury | Feb 9, 2004
Company News

ProtKinetix, University of Michigan deal

...PKTX acquired an exclusive option to license and develop a breast cancer therapy based on Mammastatin...
BioCentury | Aug 11, 2003
Company News

Corgenix Medical Corp., Genesis Bioventures deal

...the merger announcement. The merged entity will focus on the development and commercialization of GBI's Mammastatin...
BioCentury | Aug 5, 2003
Company News

Corgenix, GBI merging

...the merger announcement. The merged entity will focus on the development and commercialization of GBI's Mammastatin...
BioCentury | May 19, 2003
Company News

Genesis Bioventures, University of Michigan deal

...GBI received an exclusive worldwide license to diagnostic uses of the university's mammastatin protein technology. Mammastatin...
BioCentury | Dec 9, 2002
Company News

Genesis Bioventures, Innathera Inc. deal

...technologies with Innathera’s therapeutic compounds. The merged company will continue to develop and market GBI’s Mammastatin...
BioCentury | Jul 1, 2002
Company News

Corgenix Medical Corp., Genesis Bioventures deal

...The companies partnered to develop an Elisa-based breast cancer screening diagnostics using GBI's Mammastatin Serum Assay...
BioCentury | Dec 10, 2001
Company News

Biomedical Diagnostics LLC, Biotherapies, Genesis Bioventures deal

...cash. Under the acquisition, Biotherapies, in which GBI holds a 26% stake, will sublicense its Mammastatin...
BioCentury | Jun 4, 2001
Clinical News

Mammastatin serum assay: Began U.S. trial

...Product: Mammastatin serum assay Business: Diagnostics/Imaging Therapeutic category: Test Target: Mammastatin Description: Serum test for Mammastatin...
...End point: Detect breast cancer Status: GBI will begin a 200-patient U.S. trial of its Mammastatin...
BioCentury | May 7, 2001
Company News

Biolabs Inc. sales and marketing update

...LLC will launch in the U.S. the Mammastatin Serym Assay (MSA) test for breast cancer. Mammastatin...
Items per page:
1 - 10 of 13